0.5599
price down icon6.68%   -0.0401
after-market After Hours: .56 0.0001 +0.02%
loading

Tc Biopharm Holdings Plc Adr Stock (TCBP) Latest News

pulisher
Nov 25, 2024

TC Biopharm Faces Financial Strains Amid Rising Costs - TipRanks

Nov 25, 2024
pulisher
Nov 12, 2024

TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks

Nov 12, 2024
pulisher
Oct 30, 2024

TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India

Oct 30, 2024
pulisher
Oct 25, 2024

TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks

Oct 25, 2024
pulisher
Oct 25, 2024

TC BioPharm denies Nasdaq delisting rumors - Investing.com

Oct 25, 2024
pulisher
Oct 22, 2024

TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks

Oct 22, 2024
pulisher
Oct 21, 2024

TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks

Oct 21, 2024
pulisher
Oct 08, 2024

TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Oct 08, 2024
pulisher
Oct 05, 2024

TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks

Oct 05, 2024
pulisher
Sep 12, 2024

TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks

Sep 12, 2024
pulisher
Sep 09, 2024

TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India

Sep 09, 2024
pulisher
Sep 09, 2024

TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks

Sep 09, 2024
pulisher
Sep 06, 2024

TC BioPharm to begin monkeypox treatment studies - Investing.com

Sep 06, 2024
pulisher
Sep 04, 2024

TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle

Sep 04, 2024
pulisher
Sep 04, 2024

TC BioPharm (Holdings) plc ADR (TCBP)’s stock rises to 7.28 per share - US Post News

Sep 04, 2024
pulisher
Sep 03, 2024

TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks

Sep 03, 2024
pulisher
Aug 30, 2024

TC Biopharm Unveils New Pre-Funded Warrant - TipRanks

Aug 30, 2024
pulisher
Aug 30, 2024

Was there any good news for TC BioPharm (Holdings) plc ADR (TCBP) stock in the last session? - US Post News

Aug 30, 2024
pulisher
Aug 29, 2024

Balance Sheet Insights: TC BioPharm (Holdings) plc ADR (TCBP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Aug 29, 2024
pulisher
Aug 28, 2024

TC BioPharm secures European patent for cell therapy - Investing.com India

Aug 28, 2024
pulisher
Aug 23, 2024

TC BioPharm Regains Nasdaq Compliance - TipRanks

Aug 23, 2024
pulisher
Aug 15, 2024

TC BioPharm meets Nasdaq equity requirement - Investing.com

Aug 15, 2024
pulisher
Aug 15, 2024

TC Biopharm Unveils Pre-Funded Share Warrants - TipRanks

Aug 15, 2024
pulisher
Aug 13, 2024

TC BioPharm secures $2 million in direct offering - Investing.com

Aug 13, 2024
pulisher
Aug 08, 2024

TC Biopharm Announces Warrant Adjustment - TipRanks

Aug 08, 2024
pulisher
Aug 06, 2024

TC Biopharm At Risk of Nasdaq Delisting - TipRanks

Aug 06, 2024
pulisher
Aug 06, 2024

Upcoming Stock Splits This Week (August 5 to August 9) – Stay Invested - Yahoo Finance

Aug 06, 2024
pulisher
Aug 01, 2024

Apple Hospitality REIT Inc (APLE) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Aug 01, 2024
pulisher
Jul 31, 2024

TC BioPharm adjusts ADS to ordinary share ratio - Investing.com

Jul 31, 2024
pulisher
Jul 29, 2024

TC BioPharm Shareholders Approve Key Resolutions - TipRanks

Jul 29, 2024
pulisher
Jul 04, 2024

Is TC BioPharm (Holdings) plc ADR (TCBP) worth investing in despite its overvalued state? – US Post News - US Post News

Jul 04, 2024
pulisher
Jul 01, 2024

TC BioPharm Reschedules 2024 AGM for July - TipRanks

Jul 01, 2024
pulisher
Jun 28, 2024

TC Biopharm Board Members Resign Suddenly - TipRanks

Jun 28, 2024
pulisher
Jun 19, 2024

A year in review: TC BioPharm (Holdings) plc ADR (TCBP)'s performance in the last year – US Post News - US Post News

Jun 19, 2024
pulisher
Jun 01, 2024

TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer - The Globe and Mail

Jun 01, 2024
pulisher
May 30, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - The Globe and Mail

May 30, 2024
pulisher
May 30, 2024

TC Biopharm Announces Corporate Restructuring, Reduction in Overhead - The Globe and Mail

May 30, 2024
pulisher
May 06, 2024

TC BioPharm secures $3.1 million from warrant exercise By Investing.com - Investing.com

May 06, 2024
pulisher
May 06, 2024

Amkor Technology stock rated overweight by JPMorgan, sees strong packaging demand By Investing.com - Investing.com

May 06, 2024
pulisher
Apr 04, 2024

TC BioPharm eyes expansion with CAR-NK technology LOI - Investing.com

Apr 04, 2024
pulisher
Apr 02, 2024

TC BioPharm aims to slash cancer treatment costs By Investing.com - Investing.com

Apr 02, 2024
pulisher
Mar 14, 2024

Healthcare Stocks Making Moves Thursday: TCBP, DRRX, CLSD, XRTX, SPRB, IMRX, FWBI, RNXT - InvestorsObserver

Mar 14, 2024
pulisher
Mar 11, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 11, 2024
pulisher
Mar 11, 2024

Healthcare Stocks Making Moves Monday: TCBP, BIAF, LXRX, GRPH, LTRN, OCEA, VTYX, SKYE - InvestorsObserver

Mar 11, 2024
pulisher
Feb 22, 2024

TC BioPharm gains MHRA nod for trial amendment By Investing.com - Investing.com

Feb 22, 2024
pulisher
Feb 14, 2024

TC Biopharm Plans Share Issuance, Calls Shareholder MeetingTipRanks.com - TipRanks

Feb 14, 2024
pulisher
Feb 12, 2024

Healthcare Stocks Moving Up and Down Monday: RNLX, TTOO, CBAY, TLPH, ANTX, TCBP, IVVD, BDSX - InvestorsObserver

Feb 12, 2024
pulisher
Feb 09, 2024

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider

Feb 09, 2024
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):